跳至主要内容
临床试验/NL-OMON56423
NL-OMON56423已完成3 期

Surgical Septal Myectomy versus Percutaneous Transluminal Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy - AMARONE

Sint Antonius Ziekenhuis0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age between 30-80 years
  • 2. HOCM eligible for either SSM or ASA by a heart team (multi-disciplinary
  • 3. LVOT obstruction >=50 mmHg at rest or during physiological provocation by TTE
  • 4. Symptomatic (NYHA class >=2 ) and/or syncope due to HOCM

排除标准

  • 1. Unable to give informed consent
  • 2. A life expectancy of less than 1 year
  • 3. Concomitant intrinsic valvular disease requiring surgery in accordance with
  • current guidelines
  • 4. Concomitant coronary artery disease not amendable to PCI and thus requiring
  • coronary artery bypass surgery
  • 5. Not able to perform bicycle ergometry exercise test

研究者

相似试验